Literature DB >> 830761

Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein.

D R Claus, J Siegel, K Petras, D Skor, A P Osmand, H Gewurz.   

Abstract

Interactions between heparin and protamine previously were found to result in activation of the complement (C) system. In the present investigation, this interaction was shown to result in the binding of purified C1, and this was markedly enhanced in the presence of C-reactive protein (CRP). CRP also enhanced C consumption during heparin-protamine interactions in whole serum, and in the presence of CRP depletion of C components C1-3 was observed. Similar C1 binding and C consumption in the presence of CRP were seen upon the interaction of multiple additional polyanions including DNA, ENA, hyaluronic acid, chondroitin sulfate, and dextran sulfate with the polycations protamine sulfate and poly-L-lysine. These effects were observed with CRP concentrations well within the range found in normal human sera and considerably less than those found in most acute phase sera. We suggest, therefore, C activation by polyanion-polycation interactions in the presence of CRP may be important to certain reactions of host defense and inflammation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830761

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

2.  Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.

Authors:  F Furukawa; K Sekita; E Muso; S Imamura; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Circulating immune complexes in Plasmodium knowlesi infected Kra, and merozoite vaccinated Rhesus monkeys.

Authors:  P S Shepherd; P Burke; A Thomas; G H Mitchell; S Cohen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.

Authors:  P S Shepherd
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

Review 5.  CRP after 2004.

Authors:  Alok Agrawal
Journal:  Mol Immunol       Date:  2004-12-07       Impact factor: 4.407

6.  Longitudinal study of circulating immune complexes in a patient with Staphylococcus albus-induced shunt nephritis.

Authors:  G D Harkiss; D L Brown; D B Evans
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

7.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  'In vitro' study of a reaction between the complement system and cellular DNA.

Authors:  A P Peltier; L Cyna; A Dryll
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

9.  Fine mapping of the human pentraxin gene region on chromosome 1q23.

Authors:  M T Walsh; A Divane; A S Whitehead
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

10.  Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway.

Authors:  Sanjay Khandelwal; Joann Ravi; Lubica Rauova; Alexandra Johnson; Grace M Lee; Jennifer B Gilner; Sreenivasulu Gunti; Abner L Notkins; Maragatha Kuchibhatla; Michael Frank; Mortimer Poncz; Douglas B Cines; Gowthami M Arepally
Journal:  Blood       Date:  2018-10-11       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.